Go to ScienceDirect® Home Skip Main Navigation Links
 Register or Login:   Password:  
  Athens Login 
   
HomeSearchBrowse JournalsBrowse Abstract DatabasesBrowse BooksBrowse Reference WorksMy ProfileAlertsHelp (Opens New Window)
 Quick Search:  within Quick Search searches abstracts, titles, keywords, and authors. Click here for more information. 
Issue List
Bioorganic & Medicinal Chemistry Letters
Copyright © 2004 Elsevier Ltd. All rights reserved

Volume 14, Issue 22, Pages 5451-5713 (15 November 2004)
       Selected Display Checked Docs E-mail Articles Export Citations View:
1.
Graphical contents list CONTENTS LIST
Pages 5451-5464

PDF (1389 K)
2.
Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds SHORT COMMUNICATION
Pages 5465-5467
Geoff H. Werstuck, Anna J. Kim, Timothy Brenstrum, Stephan A. Ohnmacht, Ella Panna and Alfredo Capretta
SummaryPlus | Full Text + Links | PDF (250 K)
3.
Determination of the enantiomeric purity of the phytoalexins spirobrassinins by 1H NMR using chiral solvation SHORT COMMUNICATION
Pages 5469-5471
M.S.C. Pedras, M. Hossain, M.G. Sarwar and S. Montaut
SummaryPlus | Full Text + Links | PDF (274 K)
4.
2- 2-[3-(Pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist SHORT COMMUNICATION
Pages 5473-5476
Dehua Huang, Steve F. Poon, Deborah F. Chapman, Janice Chung, Merryl Cramer, Thomas S. Reger, Jeffrey R. Roppe, Lida Tehrani, Nicholas D.P. Cosford and Nicholas D. Smith
SummaryPlus | Full Text + Links | PDF (267 K)
5.
3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonist SHORT COMMUNICATION
Pages 5477-5480
Steve F. Poon, Brian W. Eastman, Deborah F. Chapman, Janice Chung, Merryl Cramer, Gregory Holtz, Nicholas D.P. Cosford and Nicholas D. Smith
SummaryPlus | Full Text + Links | PDF (267 K)
6.
Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity SHORT COMMUNICATION
Pages 5481-5484
Nicholas D. Smith, Steve F. Poon, Dehua Huang, Mitchell Green, Christopher King, Lida Tehrani, Jeffrey R. Roppe, Janice Chung, Deborah P. Chapman, Merryl Cramer and Nicholas D.P. Cosford
SummaryPlus | Full Text + Links | PDF (264 K)
7.
Expedited SAR study of an mGluR5 antagonists: generation of a focused library using a solution-phase Suzuki coupling methodology SHORT COMMUNICATION
Pages 5485-5488
Brian Eastman, Chixu Chen, Nicholas D. Smith, Steven Poon, Janice Chung, Grace Reyes-Manalo, Nicholas D.P. Cosford and Benito Munoz
SummaryPlus | Full Text + Links | PDF (262 K)
8.
Parallel synthesis of acylsemicarbazide libraries: preparation of potent cyclin dependent kinase (cdk) inhibitors SHORT COMMUNICATION
Pages 5489-5491
David A. Nugiel, Anup Vidwans and Carolyn D. Dzierba
SummaryPlus | Full Text + Links | PDF (254 K)
9.
Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonists SHORT COMMUNICATION
Pages 5493-5498
Steven J. Coats, Mark J. Schulz, John R. Carson, Ellen E. Codd, Dennis J. Hlasta, Philip M. Pitis, Dennis J. Stone, Jr., Sui-Po Zhang, Ray W. Colburn and Scott L. Dax
SummaryPlus | Full Text + Links | PDF (279 K)
10.
1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands SHORT COMMUNICATION
Pages 5499-5502
Ronald Bernotas, Steven Lenicek, Schuyler Antane, Guo Ming Zhang, Deborah Smith, Joseph Coupet, Boyd Harrison and Lee E. Schechter
SummaryPlus | Full Text + Links | PDF (270 K)
11.
A 13C NMR approach to categorizing potential limitations of α,β-unsaturated carbonyl systems in drug-like molecules SHORT COMMUNICATION
Pages 5503-5507
Kevin P. Cusack, Lee D. Arnold, Claude E. Barberis, Haipeng Chen, Anna M. Ericsson, Georgeen S. Gaza-Bulseco, Thomas D. Gordon, Christine M. Grinnell, Andreas Harsch, Maria Pellegrini and Edit Tarcsa
SummaryPlus | Full Text + Links | PDF (283 K)
12.
Azaadamantane benzamide 5-HT4 agonists: gastrointestinal prokinetic SC-54750 SHORT COMMUNICATION
Pages 5509-5512
Daniel P. Becker, Daniel L. Flynn, Robert L. Shone and Gary Gullikson
SummaryPlus | Full Text + Links | PDF (266 K)
13.
Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonists SHORT COMMUNICATION
Pages 5513-5519
Laykea Tafesse, Qun Sun, Lori Schmid, Kenneth J. Valenzano, Yakov Rotshteyn, Xin Su and Donald J. Kyle
SummaryPlus | Full Text + Links | PDF (308 K)
14.
Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer’s disease SHORT COMMUNICATION
Pages 5521-5525
Christopher J. Helal,Mark A. Sanner, Christopher B. Cooper, Thomas Gant, Mavis Adam, John C. Lucas, Zhijun Kang, Stanley Kupchinsky, Michael K. Ahlijanian, Bonnie Tate et al.
SummaryPlus | Full Text + Links | PDF (288 K)
15.
Synthesis and antitumor activity of 4-hydroxycoumarin derivatives SHORT COMMUNICATION
Pages 5527-5531
Jae-Chul Jung, Ji-Ho Lee, Seikwan Oh, Jae-Gon Lee and Oee-Sook Park
SummaryPlus | Full Text + Links | PDF (276 K)
16.
Novel fibrinogen receptor antagonists. RGDF mimetics, derivatives of 4-(isoindoline-5-yl)amino-4-oxobutyric acid SHORT COMMUNICATION
Pages 5533-5535
Andrei A. Krysko, Boris M. Chugunov, Olga L. Malovichko, Sergei A. Andronati, Tatyana A. Kabanova, Tamara L. Karaseva and Anna V. Kiriyak
SummaryPlus | Full Text + Links | PDF (248 K)
17.
Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists SHORT COMMUNICATION
Pages 5537-5542
Bradley Newhouse, Shelley Allen, Benjamin Fauber, Aaron S. Anderson, C. Todd Eary, Joshua D. Hansen, Justin Schiro, John J. Gaudino, Ellen Laird, David Chantry et al.
SummaryPlus | Full Text + Links | PDF (281 K)
18.
Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors SHORT COMMUNICATION
Pages 5543-5546
Hongyu Zhao, Gang Liu, Zhili Xin, Michael D. Serby, Zhonghua Pei, Bruce G. Szczepankiewicz, Philip J. Hajduk, Cele Abad-Zapatero, Charles W. Hutchins, Thomas H. Lubben et al.
SummaryPlus | Full Text + Links | PDF (301 K)
19.
Structurally simplified macrolactone analogues of halichondrin B SHORT COMMUNICATION
Pages 5547-5550
Boris M. Seletsky, Yuan Wang, Lynn D. Hawkins, Monica H. Palme, Gregory J. Habgood, Lucian V. DiPietro, Murray J. Towle, Kathleen A. Salvato, Bruce F. Wels, Kimberley K. Aalfs et al.
SummaryPlus | Full Text + Links | PDF (301 K)
20.
Macrocyclic ketone analogues of halichondrin B SHORT COMMUNICATION
Pages 5551-5554
Wanjun Zheng, Boris M. Seletsky, Monica H. Palme, Paul J. Lydon, Lori A. Singer, Charles E. Chase, Charles A. Lemelin, Yongchun Shen, Heather Davis, Lynda Tremblay et al.
SummaryPlus | Full Text + Links | PDF (303 K)
21.
An efficient approach to N-acetyl-D-glucosaminuronic acid-based sialylmimetics as potential sialidase inhibitors SHORT COMMUNICATION
Pages 5555-5558
Maretta C. Mann, Robin J. Thomson and Mark von Itzstein
SummaryPlus | Full Text + Links | PDF (267 K)
22.
An effective chromatographic separation of chicken red blood cell coproporphyrinogen oxidase and uroporphyrinogen decarboxylase, two enzymes in heme biosynthesis SHORT COMMUNICATION
Pages 5559-5564
Marjorie A. Jones, Munish Taneja, Yan Xu, Wen Chung, Christian M. Stob and Timothy D. Lash
SummaryPlus | Full Text + Links | PDF (437 K)
23.
Nitroxyl (HNO) release from new functionalized N-hydroxyurea-derived acyl nitroso-9,10-dimethylanthracene cycloadducts SHORT COMMUNICATION
Pages 5565-5568
Bu-Bing Zeng, Jinming Huang, Marcus W. Wright and S. Bruce King
SummaryPlus | Full Text + Links | PDF (281 K)
24.
Aryl urea analogs with broad-spectrum antibacterial activity SHORT COMMUNICATION
Pages 5569-5572
Punit P. Seth, Ray Ranken, Dale E. Robinson, Stephen A. Osgood, Lisa M. Risen, Elizabeth L. Rodgers, Michael T. Migawa, Elizabeth A. Jefferson and Eric E. Swayze
SummaryPlus | Full Text + Links | PDF (267 K)
25.
Nocathiacin I analogues: synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics SHORT COMMUNICATION
Pages 5573-5577
B. Narasimhulu Naidu, Margaret E. Sorenson, Yunhui Zhang, Oak K. Kim, John D. Matiskella, John A. Wichtowski, Timothy P. Connolly, Wenying Li, Kin S. Lam, Joanne J. Bronson et al.
SummaryPlus | Full Text + Links | PDF (276 K)
26.
Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors SHORT COMMUNICATION
Pages 5579-5583
Dana Ferraris, Yao-Sen Ko, David Calvin, Tiffany Chiou, Susan Lautar, Bert Thomas, Krystyna Wozniak, Camilo Rojas, Vincent Kalish and Sergei Belyakov
SummaryPlus | Full Text + Links | PDF (319 K)
27.
Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity SHORT COMMUNICATION
Pages 5585-5589
Alexander L. Ruchelman, Shejin Zhu, Nai Zhou, Angela Liu, Leroy F. Liu and Edmond J. LaVoie
SummaryPlus | Full Text + Links | PDF (274 K)
28.
Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity SHORT COMMUNICATION
Pages 5591-5594
Timothy A. Lewis, Michelle A. Young, Mark P. Arrington, Lynn Bayless, Xiong Cai, Philippe Collart, Joseph B. Eckman, James L. Ellis, Doina G. Ene, Lyn Libertine et al.
SummaryPlus | Full Text + Links | PDF (261 K)
29.
Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin SHORT COMMUNICATION
Pages 5595-5598
Krzysztof Krajewski, Christophe Marchand, Ya-Qiu Long, Yves Pommier and Peter P. Roller
SummaryPlus | Full Text + Links | PDF (291 K)
30.
Identification of neutral 4-O-alkyl quinolone nonpeptide GnRH receptor antagonists SHORT COMMUNICATION
Pages 5599-5603
Robert J. DeVita, Mamta Parikh, Jinlong Jiang, Jason A. Fair, Jonathan R. Young, Thomas F. Walsh, Mark T. Goulet, Jane-L. Lo, Ning Ren, Joel B. Yudkovitz et al.
SummaryPlus | Full Text + Links | PDF (287 K)
31.
Piperazinebenzylamines as potent and selective antagonists of the human melanocortin-4 receptor SHORT COMMUNICATION
Pages 5605-5609
Joseph Pontillo, Joseph A. Tran, Beth A. Fleck, Dragan Marinkovic, Melissa Arellano, Fabio C. Tucci, Marion Lanier, Jodie Nelson, Jessica Parker, JohnSaunders et al.
SummaryPlus | Full Text + Links | PDF (296 K)
32.
QSAR modeling of the MAO inhibitory activity of xanthones derivatives SHORT COMMUNICATION
Pages 5611-5617
M.B. Núñez, F.P. Maguna, N.B. Okulik and E.A. Castro
SummaryPlus | Full Text + Links | PDF (291 K)
33.
Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and its antagonistic effect on haloperidol-induced catalepsy in mice SHORT COMMUNICATION
Pages 5619-5621
Manabu Nakazono, Shigeo Hasegawa, Tsuneyuki Yamamoto and Kiyoshi Zaitsu
SummaryPlus | Full Text + Links | PDF (253 K)
34.
Antioxidant activities of a new lignan and a neolignan from Saururus chinensis SHORT COMMUNICATION
Pages 5623-5628
Woo Song Lee, Young-Il Baek, Ju-Ryoung Kim, Kyung-Hyun Cho, Dai-Eun Sok and Tae-Sook Jeong
SummaryPlus | Full Text + Links | PDF (343 K)
35.
Quantitative structure–activity relationship analyses of antioxidant and free radical scavenging activities for hydroxybenzalacetones SHORT COMMUNICATION
Pages 5629-5633
Chisako Yamagami, Noriko Motohashi, Tatsuhiko Emoto, Akira Hamasaki, Takao Tanahashi, Naotaka Nagakura and Yoshito Takeuchi
SummaryPlus | Full Text + Links | PDF (281 K)
36.
Synthesis and amine transporter affinities of novel phenyltropane derivatives as potential positron emission tomography (PET) imaging agents SHORT COMMUNICATION
Pages 5635-5639
Xuemei Peng, Ao Zhang, Nora S. Kula, Ross J. Baldessarini and John L. Neumeyer
SummaryPlus | Full Text + Links | PDF (277 K)
37.
Synthesis of 5′-substituted fluoro-neplanocin A analogues: importance of a hydrogen bonding donor at 5′-position for the inhibitory activity of S-adenosylhomocysteine hydrolase SHORT COMMUNICATION
Pages 5641-5644
Hyung Ryong Moon, Hyun Joo Lee, Kyung Ran Kim, Kang Man Lee, Sang Kook Lee, Hea Ok Kim, Moon Woo Chun and Lak Shin Jeong
SummaryPlus | Full Text + Links | PDF (282 K)
38.
Identification and structure–activity relationship studies of 3-methylene-2-norbornanone as potent anti-proliferative agents presumably working through p53 mediated apoptosis SHORT COMMUNICATION
Pages 5645-5649
N. Laxma Reddy, Jeanette Hill, Long Ye, Prabhavathi B. Fernandes and David M. Stout
SummaryPlus | Full Text + Links | PDF (270 K)
39.
Synthesis and CYP24 inhibitory activity of 2-substituted-3,4-dihydro-2H-naphthalen-1-one (tetralone) derivatives SHORT COMMUNICATION
Pages 5651-5654
Sook Wah Yee and Claire Simons
SummaryPlus | Full Text + Links | PDF (257 K)
40.
Proposal of new modification technique for linear double-stranded DNAs using the polysaccharide schizopyllan SHORT COMMUNICATION
Pages 5655-5659
Takahisa Anada, Hideshi Matsunaga, Ryouji Karinaga, Kazuya Koumoto, Masami Mizu, Koji Nakano, Seiji Shinkai and Kazuo Sakurai
SummaryPlus | Full Text + Links | PDF (386 K)
41.
Topological modeling of lipophilicity, diuretic activity, and carbonic inhibition activity of benzene sulfonamides: a molecular connectivity approach SHORT COMMUNICATION
Pages 5661-5666
Mona Jaiswal, Padmakar V. Khadikar and Claudiu T. Supuran
SummaryPlus | Full Text + Links | PDF (277 K)
42.
Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation SHORT COMMUNICATION
Pages 5667-5672
Thomas Doundoulakis, Alan X. Xiang, Ricardo Lira, Konstantinos A. Agrios, Stephen E. Webber, Wes Sisson, Robert M. Aust, Amit M. Shah, Richard E. Showalter, James R. Appleman and Klaus B. Simonsen
SummaryPlus | Full Text + Links | PDF (330 K)
43.
Preparation of a tritiated ginkgolide SHORT COMMUNICATION
Pages 5673-5675
Kristian Strømgaard, Makiko Suehiro and Koji Nakanishi
SummaryPlus | Full Text + Links | PDF (297 K)
44.
Intact glycation end products containing carboxymethyl-lysine and glyoxal lysine dimer obtained from synthetic collagen model peptide SHORT COMMUNICATION
Pages 5677-5680
Hiroaki Yamada, Tomoko Sasaki, Sachiko Niwa, Tohru Oishi, Michio Murata, Toru Kawakami and Saburo Aimoto
SummaryPlus | Full Text + Links | PDF (276 K)
45.
Pyrazolo[1,5-a]pyrimidines as estrogen receptor ligands: defining the orientation of a novel heterocyclic core SHORT COMMUNICATION
Pages 5681-5684
Dennis R. Compton, Kathryn E. Carlson and John A. Katzenellenbogen
SummaryPlus | Full Text + Links | PDF (317 K)
46.
Potent inhibitors of the HIV-1 protease incorporating cyclic urea P1–P2 scaffold SHORT COMMUNICATION
Pages 5685-5687
Wieslaw M. Kazmierski, Eric Furfine, Yolanda Gray-Nunez, Andrew Spaltenstein and Lois Wright
SummaryPlus | Full Text + Links | PDF (267 K)
47.
Discovery of potent pyrrolidone-based HIV-1 protease inhibitors with enhanced drug-like properties SHORT COMMUNICATION
Pages 5689-5692
Wieslaw M. Kazmierski, Webb Andrews, Eric Furfine, Andrew Spaltenstein and Lois Wright
SummaryPlus | Full Text + Links | PDF (300 K)
48.
Azepinone as a conformational constraint in the design of κ-opioid receptor agonists SHORT COMMUNICATION
Pages 5693-5697
Paul A. Tuthill, Pamela R. Seida, William Barker, Joel A. Cassel, Serge Belanger, Robert N. DeHaven, Michael Koblish, Susan L. Gottshall, Patrick J. Little, Diane L. DeHaven-Hudkins and Roland E. Dolle
SummaryPlus | Full Text + Links | PDF (370 K)
49.
Synthesis of fluorinated analogues of SJG-136 and their DNA-binding potential SHORT COMMUNICATION
Pages 5699-5702
Ahmed Kamal, P.S.M.M. Reddy, D. Rajasekhar Reddy, E. Laxman and Y.L.N. Murthy
SummaryPlus | Full Text + Links | PDF (284 K)
50.
Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives SHORT COMMUNICATION
Pages 5703-5707
Alessio Innocenti, Jochen Antel, Michael Wurl, Andrea Scozzafava and Claudiu T. Supuran
SummaryPlus | Full Text + Links | PDF (269 K)
51.
Synthesis, radiolabeling, and preliminary biological evaluation of [3H]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl)-piperazine, a potent antagonist radioligand for the P2X7 receptor SHORT COMMUNICATION
Pages 5709-5712
Romeo Romagnoli, Pier Giovanni Baraldi, Maria Giovanna Pavani, Mojgan Aghazadeh Tabrizi, Allan R. Moorman, Francesco Di Virgilio, Elena Cattabriga, Cecilia Pancaldi, Stefania Gessi and Pier Andrea Borea
SummaryPlus | Full Text + Links | PDF (284 K)
52.
Corrigendum to “Epibatidine structure–activity relationships”: [Bioorg. Med. Chem. Lett. 14 (2004) 1889] ERRATUM
Pages 5713-5713
F. Ivy Carroll
SummaryPlus | Full Text + Links | PDF (212 K)
53.
Editorial board EDITORIAL BOARD
Pages CO2-CO2

PDF (319 K)
54.
Contributors to this issue INDEX
Pages I-II

PDF (190 K)
55.
Instructions to contributors PUBLISHER'S NOTE
Pages III-VI

PDF (70 K)

Issue List
HomeSearchBrowse JournalsBrowse Abstract DatabasesBrowse BooksBrowse Reference WorksMy ProfileAlertsHelp (Opens New Window)

Feedback  |  Terms & Conditions  |  Privacy Policy

Copyright © 2004 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.